山东威高集团医用高分子制品股份有限公司（威高股份，股票代码01066）于2026年4月21日公告，4月21日在香港联交所场内回购股份34万股，占公司当日已发行股本约0.0076%。本次回购每股价格介乎港币3.61元至3.67元，合计耗资约港币123.48万元。
本次回购后，公司已发行股本由约44.70亿股降至约44.70亿股，库藏股相应增至约5228.56万股。公司购回授权于2025年5月27日获得通过，授权可回购股数为4.51560392亿股，截至目前累计回购约4563.72万股，约占授权额度的10.11%。
公司在公告中确认已遵守香港联交所上市规则及相关法律规定。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.